Drug Development Pipeline
Restore CFTR Function
Nesolicaftor is a type of modulator called an amplifier. Amplifiers increase the amount of CFTR protein in the cell. This makes more CFTR protein available for other therapies, such correctors and potentiators, to work on.
Phase 2 studies were conducted to test the safety and effectiveness of nesolicaftor alone and in combination with two other CFTR modulators, posenacaftor (PTI-801) and dirocaftor (PTI-808). No further studies of these compounds are planned at this time.
This program was sponsored by Proteostasis Therapeutics. It was conducted through the Therapeutics Development Network.
Recent Nesolicaftor (PTI-428) Studies
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.Learn More